WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007087453) COMPOSITIONS AND METHODS FOR TREATING HAEMATOLOGICAL PROLIFERATIVE DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/087453    International Application No.:    PCT/US2007/002390
Publication Date: 02.08.2007 International Filing Date: 29.01.2007
IPC:
C07K 16/28 (2006.01), C07K 16/30 (2006.01), A61K 39/395 (2006.01)
Applicants: CELLERANT THERAPEUTICS, INC. [US/US]; 1531 Industrial Road, San Carlos, CA 94070 (US) (For All Designated States Except US).
FONG, Timothy, C. [US/US]; (US) (For US Only).
PALATH, Varghese [US/US]; (US) (For US Only).
TESI, R., J. [US/US]; (US) (For US Only).
HOANG, Tran [US/US]; (US) (For US Only).
WEISSMAN, Irving, Dr. [US/US]; (US) (For US Only)
Inventors: FONG, Timothy, C.; (US).
PALATH, Varghese; (US).
TESI, R., J.; (US).
HOANG, Tran; (US).
WEISSMAN, Irving, Dr.; (US)
Agent: BERNHARDT, Jeffrey, P.; Dorsey & Whitney LLP, 555 California Street, Ste. 1000, San Francisco, CA 94104-1513 (US)
Priority Data:
60/762,610 27.01.2006 US
60/764,090 31.01.2006 US
60/836,624 08.08.2006 US
60/827,515 29.09.2006 US
Title (EN) COMPOSITIONS AND METHODS FOR TREATING HAEMATOLOGICAL PROLIFERATIVE DISORDERS
(FR) COMPOSITIONS ET MÉTHODES DE TRAITEMENT DE TROUBLES PROLIFÉRATIFS HÉMATOLOGIQUES
Abstract: front page image
(EN)The disclosure relates to antibodies immunoreactive with CD45RA+ hematopoietic tumor cells (HTCs), hybridomas producing such antibodies, and methods of using the antibodies, particularly as therapeutic treatments for conditions or diseases characterized by CD45RA+ HTCs.
(FR)L'invention a trait à des anticorps immunoréactifs avec les cellules souches hémotopoïétiques (HTC) CD45RA+, à des hybridomes produisant de tels anticorps, et à des procédés d'utilisation desdits anticorps, en particulier sous forme de traitements thérapeutiques d'affections ou de maladies caractérisées par les HTC CD45RA+.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)